Evidence map›Paper›PMID 35514309›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2022

Behavioural insights and the evolving COVID-19 pandemic.

Marijn de Bruin, Jonathan E Suk, Marianna Baggio, Sarah Earnshaw Blomquist, María Falcon, Maria João Forjaz, Karina Godoy-Ramirez, Mariken Leurs, Carmen Rodriguez-Blazquez, María Romay-Barja and 2 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marijn de BruinNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Jonathan E SukEuropean Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
Marianna BaggioJoint Research Centre, European Commission, Brussels, Belgium.
Sarah Earnshaw BlomquistThe Public Health Agency of Sweden, Solna, Sweden.
María FalconDepartment of Legal and Forensic Medicine, Faculty of Medicine, Biomedical Research Institute (IMIB), University of Murcia, Murcia, Spain.
Maria João ForjazNational Epidemiology Centre, Carlos III Health Institute, Madrid, Spain.
Karina Godoy-RamirezThe Public Health Agency of Sweden, Solna, Sweden.
Mariken LeursNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Carmen Rodriguez-BlazquezNational Epidemiology Centre, Carlos III Health Institute, Madrid, Spain.
María Romay-BarjaInfectious Disease Network Research Center (CIBERINFEC), Madrid, Spain.
Ellen UitersNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
John KinsmanEuropean Centre for Disease Prevention and Control (ECDC), Solna, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Behavioural sciences have complemented medical and epidemiological sciences in the response to the SARS-CoV-2 pandemic. As vaccination uptake continues to increase across the EU/EEA - including booster vaccinations - behavioural science research remains important for both pandemic policy, planning of services and communication. From a behavioural perspective, the following three areas are key as the pandemic progresses: (i) attaining and maintaining high levels of vaccination including booster doses across all groups in society, including socially vulnerable populations, (ii) informing sustainable pandemic policies and ensuring adherence to basic prevention measures to protect the most vulnerable population, and (iii) facilitating population preparedness and willingness to support and adhere to the reimposition of restrictions locally or regionally whenever outbreaks may occur. Based on mixed-methods research, expert consultations, and engagement with communities, behavioural data and interventions can thus be important to prevent and effectively respond to local or regional outbreaks, and to minimise socioeconomic and health disparities. In this Perspective, we briefly outline these topics from a European viewpoint, while recognising the importance of considering the specific context in individual countries.

Indexed as

COVID-19HumansPandemicsSARS-CoV-2VaccinationBehavioural scienceCOVID-19pandemicpandemic preparednesspreventionvaccination

Identifiers

PMID35514309
PMCPMC9074394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.